Advertisement

Shadowfax Applied sciences information confidential DRHP for Rs 2,500 crore IPO with Sebi


Thank you for reading this post, don't forget to subscribe!
Shadowfax Applied sciences has filed a confidential draft pink herring prospectus with the Securities and Alternate Board of India (Sebi) for an preliminary public providing. As per sources, the IPO measurement is predicted to be within the vary of Rs 2,000 – Rs 2,500 crore, comprising a mixture of contemporary difficulty and supply on the market (OFS) by present shareholders. The corporate is predicted to be valued at round Rs 8,500 crore.

The corporate plans to utilise the proceeds from the contemporary difficulty in direction of enhancing capability, driving development, and additional investments within the firm’s community enterprise, based on sources.

In a public announcement on Tuesday, Shadowfax Applied sciences mentioned it has “pre-filed draft pink herring prospectus with Sebi and the inventory exchanges…in relation to the proposed preliminary public providing of its fairness shares on the main-board of the inventory exchanges”.

In its final fundraise in February 2025, the corporate raised main and secondary capital at an approximate valuation of Rs. 6,000 crore.

Additionally Learn | Confused about funding in shares, gold & silver? Simplify it with multi-asset mutual funds!


The e-commerce section is the main income contributor, accounting for round 75% of the enterprise. The remaining comes from fast commerce and hyperlocal deliveries.Shadowfax is backed by marquee traders corresponding to Flipkart, TPG, Eight Roads Ventures, Mirae Asset Ventures and Nokia Development Funds.Shadowfax stands as India’s main logistics service supplier for e-commerce, specific parcel and value-added providers. With a strong distribution community masking over 2,200+ cities and greater than 14,300 PIN codes, Shadowfax has established itself as a market chief within the logistics business.

In its final fundraise in February, the corporate garnered main and secondary capital at an approximate valuation of Rs 6,000 crore.

Additionally Learn | Curefoods India information DRHP with Sebi for Rs 800 crore IPO. Test Particulars

The corporate has chosen the confidential pre-filing route for its IPO, enabling it to delay public disclosure of supply particulars till a later stage. This methodology is more and more being utilized by Indian firms in search of larger flexibility of their itemizing course of.

In line with market consultants, the confidential pre-filing route offers firms with larger flexibility and eases the urgency to listing. Not like the standard course of—which requires an IPO launch inside 12 months of SEBI approval—the pre-filing pathway permits as much as 18 months from the receipt of ultimate feedback. It additionally permits firms to revise the first difficulty measurement by as a lot as 50% till the up to date DRHP is filed.

(Disclaimer: Suggestions, solutions, views and opinions given by the consultants are their very own. These don’t characterize the views of Financial Instances)